Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hanhee Jo"'
Autor:
Sua Cho, Wonjin Kim, Dayoung Yoo, Yeonju Han, Hyemin Hwang, Seunghwan Kim, Jimin Kim, Sanghee Park, Yusun Park, HanHee Jo, Jae-chul Pyun, Misu Lee
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality worldwide. Programmed cell death ligand-1 (PD-L1) is an immune checkpoint protein that binds to programmed cell death-1 (PD-1), which is expressed in activ
Externí odkaz:
https://doaj.org/article/3ecf5e71e2564a028f2d97e183f5114d
Autor:
Yen N. Diep, Hee Jung Park, Joon-Ho Kwon, Minh Tran, Hae Young Ko, Hanhee Jo, Jisu Kim, Jee-In Chung, Tai Young Kim, Dongwoo Kim, Jong Hee Chang, You Jung Kang, C. Justin Lee, Mijin Yun, Hansang Cho
Publikováno v:
Biomaterials Research, Vol 27, Iss 1, Pp 1-19 (2023)
Abstract Background Glial scar formation is a reactive glial response confining injured regions in a central nervous system. However, it remains challenging to identify key factors formulating glial scar in response to glioblastoma (GBM) due to compl
Externí odkaz:
https://doaj.org/article/32760ab156ad4f80bd86f612c085d2aa
Autor:
Hanhee Jo, Yusun Park, Taehun Kim, Jisu Kim, Jong Sook Lee, Seon Yoo Kim, Jee-in Chung, Hae yong Ko, Jae-Chul Pyun, Kyung Sik Kim, Misu Lee, Mijin Yun
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced
Externí odkaz:
https://doaj.org/article/7200f5ef294141cbb9c84376afdd7946
Autor:
HanHee Jo, Yusun Park, Jisu Kim, Hyeonjeong Kwon, Taehun Kim, JongSook Lee, Jae-Chul Pyun, Misu Lee, Mijin Yun
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240107 (2020)
Somatostatin analogs, which are used to treat neuroendocrine tumors, inhibit hormone secretion or promote tumor shrinkage; however, their efficacy varies between patients, possibly because of differential expression of somatostatin receptors (SSTRs)
Externí odkaz:
https://doaj.org/article/285d8273b53040ccb409a041dde53a13
Autor:
Jae Chul Pyun, Zhiquan Song, Yusun Park, Tae Hun Kim, Mijin Yun, Jong Sook Lee, Hanhee Jo, Misu Lee
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
In this work, the influence of parylene N film on the spheroid formation of osteoblast-like cells (MG-63) was determined and compared with that of high-hydrophilicity microenvironments, such as hydrophilic culture matrix and ultraviolet-treated paryl
Autor:
Seon Yoo Kim, Jae Chul Pyun, Jisu Kim, Hae Yong Ko, Jong Sook Lee, Yusun Park, Hanhee Jo, Misu Lee, Kyung Sik Kim, Mijin Yun, Jee In Chung, Tae Hun Kim
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-15 (2020)
Background Hepatocellular carcinoma (HCC) is the leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced sensitivi
Autor:
Seon Yoo Kim, Jeong Yong Jeon, Misu Lee, Mijin Yun, Jee-In Chung, Jong Sook Lee, Hae Yong Ko, Hanhee Jo
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Scientific Reports
Scientific Reports
Imaging with 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is used to determine sites of abnormal glucose metabolism to predict high tumor grade, metastasis, and poor patient survival. However, not all tumors
Autor:
Hanhee Jo, Yusun Park, Taehun Kim, Jisu Kim, Lee, Jong Sook, Kim, Seon Yoo, Jee-In Chung, Ko, Hae Yong, Jae-Chul Pyun, Kim, Kyung Sik, Lee, Misu, Mijin Yun
Additional file 2 Figure S1. Full-length original blots of Fig. 2b. Figure S2. Full-length original blots of Fig. 2d. Figure S3. Full-length original blots of Fig. 3a. Figure S4. Full-length original blots of Fig. 3b. Figure S5. Full-length original
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01cda8542791c78b6133f26bf002097c
Autor:
Hanhee Jo, Yusun Park, Taehun Kim, Jisu Kim, Lee, Jong Sook, Kim, Seon Yoo, Jee-In Chung, Ko, Hae Yong, Jae-Chul Pyun, Kim, Kyung Sik, Lee, Misu, Mijin Yun
Additional file 1 Supplementary Data 1. Quantification of immunostaining. (A, C) Mean fluorescent intensity (MFI) indicating the expression of (A) SIRT3 and membranous (C) GLUT1 from 12 patients with high FDG uptake (n = 6) and low FDG uptake (n = 6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b407c5a0d0359a7c79aec617a1d973e4
Autor:
HanHee Jo, Dayoung Yoo, JongSook Lee, Seon yoo Kim, Jee-in Chung, Hae yong Ko, Misu Lee, Mijin Yun
Background : Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related deaths worldwide. The only drug currently approved for clinical use in the treatment of advanced HCC is sorafenib. However, many patients with HCC show reduced s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fac87fdb9ce7670aff7fe8a29a826c81
https://doi.org/10.21203/rs.2.16163/v1
https://doi.org/10.21203/rs.2.16163/v1